TIGIT and pancreatic neoplasm: While a recent phase III trial of tiragolumab as first line therapy in small cell lung cancer was unsuccessful68, the Morpheus-Pancreatic Cancer trial (NCT03193190) is investigating the effect of TIGIT blockage in metastatic PDAC and will hopefully provide more insight into the clinical relevance of TIGIT inhibition in PDAC.